Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma.
Natsumeda, Manabu *,1,2; Liu, Yang 1; Nakata, Satoshi 1; Miyahara, Hiroaki 1,3; Hanaford, Allison 1; Ahsan, Sama 1; Stearns, Duncan 4; Skuli, Nicolas 5; Kahlert, Ulf D. 6; Raabe, Eric H. 1,7; Rodriguez, Fausto J. 1; Eberhart, Charles G. 1
[Article]
Neuropathology.
39(2):71-77, April 2019.
(Format: HTML, PDF)